Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on Dapsone vs Methotrexate in Bullous Pemphigoid
NCT05984381Phase 4Completed
- Sponsor
- AIIMS New Delhi
- Start
- Aug 2023
- Primary completion
- Jan 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of dapsone in Bullous Pemphigoid (BP), sponsored by AIIMS New Delhi. Started Aug 2023; status: completed.
02
Drugs
dapsone
03
Conditions
Bullous Pemphigoid (BP)
Beyond the preview
Go deeper on NCT05984381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05984381.